Global Respiratory Devices

Respiratory Devices Comprehensive Study by Type (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Infectious Disease, Other), End-Use (Hospital, Home Care, Ambulatory Care Centers) Players and Region - Global Market Outlook to 2025

Respiratory Devices Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Respiratory Devices Market Overview:
Respiratory devices supply respiratory gas instinctively to patients with impaired respiratory function. The respiratory gas is typically enhanced with oxygen and conveyed into the lung with a positive pressure created by the device. During controlled respiration, the ventilator fully assumes the patient's respiration effort with predetermined respiratory volume or pressures, while in assisted respiration the respiratory device only supports the spontaneous breathing effort with a set overpressure. Modern respiratory devices automatically regulate the inhalations and exhalations as per the requirement of the patients. Respiratory devices are available in different varieties as emergency respiratory devices for long-term respiratory devices for intensive care and mobile home respiratory devices.

Market Drivers
  • Increasing Prevalence of Respiratory Diseases
  • Strict Government Regulations Regarding the Use of Respiratory Protection Equipment Mask

Market Trend
  • Rising Demand for Home Care Respiratory Devices
  • Rising Awareness Associated With Individual Safety and Security at Workplace

Restraints
  • Lack of Awareness about Respiratory Protection Equipment in Developing Region

Opportunities
  • Increasing Awareness and Improvement in the Healthcare Infrastructure in Emerging Economies
  • Huge Demand for Diagnostic Tools to Deliver a Reliable Diagnosis of Asthma in Young Children

Challenges
  • Availability of Substitutes in Market


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined synergies.
Some of the key players profiled in the report are First Sensor AG (Germany), Philips Healthcare, (Netherlands), Medtronic plc (Ireland), ResMed Inc. (United States), Masimo Corporation (United States), Fisher & Paykel Healthcare Co. Ltd. (NewZealand), Getinge AB (Sweden), Air Liquide (France), Drägerwerk AG & CO.KGAA (Germany), Hamilton Medical AG (Switzerland), Invacare Corporation (United States), Vyaire Medical (United States) and Chart Industries, Inc. (United States). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Respiratory Devices market by 2025. Considering Market by End-Use, the sub-segment i.e. Hospital will boost the Respiratory Devices market.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Respiratory Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Respiratory Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Respiratory Device, Suppliers of Respiratory Device, Wholesalers, Distributors and Retailers of Respiratory Device, Healthcare Industry, Regulatory Bodies and Governmental Bodies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Therapeutic [Ventilator, Mask, PAP Device, Inhaler, Nebulizer]
  • Monitoring [Pulse Oximeter, Capnograph]
  • Diagnostic
  • Consumables
By Application
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Sleep Apnea
  • Infectious Disease
  • Other
By End-Use
  • Hospital
  • Home Care
  • Ambulatory Care Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Respiratory Diseases
      • 3.2.2. Strict Government Regulations Regarding the Use of Respiratory Protection Equipment Mask
    • 3.3. Market Challenges
      • 3.3.1. Availability of Substitutes in Market
    • 3.4. Market Trends
      • 3.4.1. Rising Demand for Home Care Respiratory Devices
      • 3.4.2. Rising Awareness Associated With Individual Safety and Security at Workplace
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Respiratory Devices, by Type, Application, End-Use and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Respiratory Devices (Value)
      • 5.2.1. Global Respiratory Devices by: Type (Value)
        • 5.2.1.1. Therapeutic [Ventilator, Mask, PAP Device, Inhaler, Nebulizer]
        • 5.2.1.2. Monitoring [Pulse Oximeter, Capnograph]
        • 5.2.1.3. Diagnostic
        • 5.2.1.4. Consumables
      • 5.2.2. Global Respiratory Devices by: Application (Value)
        • 5.2.2.1. Chronic Obstructive Pulmonary Disease (COPD)
        • 5.2.2.2. Asthma
        • 5.2.2.3. Sleep Apnea
        • 5.2.2.4. Infectious Disease
        • 5.2.2.5. Other
      • 5.2.3. Global Respiratory Devices by: End-Use (Value)
        • 5.2.3.1. Hospital
        • 5.2.3.2. Home Care
        • 5.2.3.3. Ambulatory Care Centers
      • 5.2.4. Global Respiratory Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Respiratory Devices (Volume)
      • 5.3.1. Global Respiratory Devices by: Type (Volume)
        • 5.3.1.1. Therapeutic [Ventilator, Mask, PAP Device, Inhaler, Nebulizer]
        • 5.3.1.2. Monitoring [Pulse Oximeter, Capnograph]
        • 5.3.1.3. Diagnostic
        • 5.3.1.4. Consumables
      • 5.3.2. Global Respiratory Devices by: Application (Volume)
        • 5.3.2.1. Chronic Obstructive Pulmonary Disease (COPD)
        • 5.3.2.2. Asthma
        • 5.3.2.3. Sleep Apnea
        • 5.3.2.4. Infectious Disease
        • 5.3.2.5. Other
      • 5.3.3. Global Respiratory Devices by: End-Use (Volume)
        • 5.3.3.1. Hospital
        • 5.3.3.2. Home Care
        • 5.3.3.3. Ambulatory Care Centers
      • 5.3.4. Global Respiratory Devices Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Respiratory Devices (Price)
      • 5.4.1. Global Respiratory Devices by: Type (Price)
  • 6. Respiratory Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. First Sensor AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Philips Healthcare, (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic plc (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. ResMed Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Masimo Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Fisher & Paykel Healthcare Co. Ltd. (NewZealand)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Getinge AB (Sweden)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Air Liquide (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Drägerwerk AG & CO.KGAA (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Hamilton Medical AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Invacare Corporation (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Vyaire Medical (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Chart Industries, Inc. (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Respiratory Devices Sale, by Type, Application, End-Use and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Respiratory Devices (Value)
      • 7.2.1. Global Respiratory Devices by: Type (Value)
        • 7.2.1.1. Therapeutic [Ventilator, Mask, PAP Device, Inhaler, Nebulizer]
        • 7.2.1.2. Monitoring [Pulse Oximeter, Capnograph]
        • 7.2.1.3. Diagnostic
        • 7.2.1.4. Consumables
      • 7.2.2. Global Respiratory Devices by: Application (Value)
        • 7.2.2.1. Chronic Obstructive Pulmonary Disease (COPD)
        • 7.2.2.2. Asthma
        • 7.2.2.3. Sleep Apnea
        • 7.2.2.4. Infectious Disease
        • 7.2.2.5. Other
      • 7.2.3. Global Respiratory Devices by: End-Use (Value)
        • 7.2.3.1. Hospital
        • 7.2.3.2. Home Care
        • 7.2.3.3. Ambulatory Care Centers
      • 7.2.4. Global Respiratory Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Respiratory Devices (Volume)
      • 7.3.1. Global Respiratory Devices by: Type (Volume)
        • 7.3.1.1. Therapeutic [Ventilator, Mask, PAP Device, Inhaler, Nebulizer]
        • 7.3.1.2. Monitoring [Pulse Oximeter, Capnograph]
        • 7.3.1.3. Diagnostic
        • 7.3.1.4. Consumables
      • 7.3.2. Global Respiratory Devices by: Application (Volume)
        • 7.3.2.1. Chronic Obstructive Pulmonary Disease (COPD)
        • 7.3.2.2. Asthma
        • 7.3.2.3. Sleep Apnea
        • 7.3.2.4. Infectious Disease
        • 7.3.2.5. Other
      • 7.3.3. Global Respiratory Devices by: End-Use (Volume)
        • 7.3.3.1. Hospital
        • 7.3.3.2. Home Care
        • 7.3.3.3. Ambulatory Care Centers
      • 7.3.4. Global Respiratory Devices Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Respiratory Devices (Price)
      • 7.4.1. Global Respiratory Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Respiratory Devices: by Type(USD Million)
  • Table 2. Respiratory Devices Therapeutic [Ventilator, Mask, PAP Device, Inhaler, Nebulizer] , by Region USD Million (2014-2019)
  • Table 3. Respiratory Devices Monitoring [Pulse Oximeter, Capnograph] , by Region USD Million (2014-2019)
  • Table 4. Respiratory Devices Diagnostic , by Region USD Million (2014-2019)
  • Table 5. Respiratory Devices Consumables , by Region USD Million (2014-2019)
  • Table 6. Respiratory Devices: by Application(USD Million)
  • Table 7. Respiratory Devices Chronic Obstructive Pulmonary Disease (COPD) , by Region USD Million (2014-2019)
  • Table 8. Respiratory Devices Asthma , by Region USD Million (2014-2019)
  • Table 9. Respiratory Devices Sleep Apnea , by Region USD Million (2014-2019)
  • Table 10. Respiratory Devices Infectious Disease , by Region USD Million (2014-2019)
  • Table 11. Respiratory Devices Other , by Region USD Million (2014-2019)
  • Table 12. Respiratory Devices: by End-Use(USD Million)
  • Table 13. Respiratory Devices Hospital , by Region USD Million (2014-2019)
  • Table 14. Respiratory Devices Home Care , by Region USD Million (2014-2019)
  • Table 15. Respiratory Devices Ambulatory Care Centers , by Region USD Million (2014-2019)
  • Table 16. South America Respiratory Devices, by Country USD Million (2014-2019)
  • Table 17. South America Respiratory Devices, by Type USD Million (2014-2019)
  • Table 18. South America Respiratory Devices, by Application USD Million (2014-2019)
  • Table 19. South America Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 20. Brazil Respiratory Devices, by Type USD Million (2014-2019)
  • Table 21. Brazil Respiratory Devices, by Application USD Million (2014-2019)
  • Table 22. Brazil Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 23. Argentina Respiratory Devices, by Type USD Million (2014-2019)
  • Table 24. Argentina Respiratory Devices, by Application USD Million (2014-2019)
  • Table 25. Argentina Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 26. Rest of South America Respiratory Devices, by Type USD Million (2014-2019)
  • Table 27. Rest of South America Respiratory Devices, by Application USD Million (2014-2019)
  • Table 28. Rest of South America Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 29. Asia Pacific Respiratory Devices, by Country USD Million (2014-2019)
  • Table 30. Asia Pacific Respiratory Devices, by Type USD Million (2014-2019)
  • Table 31. Asia Pacific Respiratory Devices, by Application USD Million (2014-2019)
  • Table 32. Asia Pacific Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 33. China Respiratory Devices, by Type USD Million (2014-2019)
  • Table 34. China Respiratory Devices, by Application USD Million (2014-2019)
  • Table 35. China Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 36. Japan Respiratory Devices, by Type USD Million (2014-2019)
  • Table 37. Japan Respiratory Devices, by Application USD Million (2014-2019)
  • Table 38. Japan Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 39. India Respiratory Devices, by Type USD Million (2014-2019)
  • Table 40. India Respiratory Devices, by Application USD Million (2014-2019)
  • Table 41. India Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 42. South Korea Respiratory Devices, by Type USD Million (2014-2019)
  • Table 43. South Korea Respiratory Devices, by Application USD Million (2014-2019)
  • Table 44. South Korea Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 45. Taiwan Respiratory Devices, by Type USD Million (2014-2019)
  • Table 46. Taiwan Respiratory Devices, by Application USD Million (2014-2019)
  • Table 47. Taiwan Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 48. Australia Respiratory Devices, by Type USD Million (2014-2019)
  • Table 49. Australia Respiratory Devices, by Application USD Million (2014-2019)
  • Table 50. Australia Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 51. Rest of Asia-Pacific Respiratory Devices, by Type USD Million (2014-2019)
  • Table 52. Rest of Asia-Pacific Respiratory Devices, by Application USD Million (2014-2019)
  • Table 53. Rest of Asia-Pacific Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 54. Europe Respiratory Devices, by Country USD Million (2014-2019)
  • Table 55. Europe Respiratory Devices, by Type USD Million (2014-2019)
  • Table 56. Europe Respiratory Devices, by Application USD Million (2014-2019)
  • Table 57. Europe Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 58. Germany Respiratory Devices, by Type USD Million (2014-2019)
  • Table 59. Germany Respiratory Devices, by Application USD Million (2014-2019)
  • Table 60. Germany Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 61. France Respiratory Devices, by Type USD Million (2014-2019)
  • Table 62. France Respiratory Devices, by Application USD Million (2014-2019)
  • Table 63. France Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 64. Italy Respiratory Devices, by Type USD Million (2014-2019)
  • Table 65. Italy Respiratory Devices, by Application USD Million (2014-2019)
  • Table 66. Italy Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 67. United Kingdom Respiratory Devices, by Type USD Million (2014-2019)
  • Table 68. United Kingdom Respiratory Devices, by Application USD Million (2014-2019)
  • Table 69. United Kingdom Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 70. Netherlands Respiratory Devices, by Type USD Million (2014-2019)
  • Table 71. Netherlands Respiratory Devices, by Application USD Million (2014-2019)
  • Table 72. Netherlands Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 73. Rest of Europe Respiratory Devices, by Type USD Million (2014-2019)
  • Table 74. Rest of Europe Respiratory Devices, by Application USD Million (2014-2019)
  • Table 75. Rest of Europe Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 76. MEA Respiratory Devices, by Country USD Million (2014-2019)
  • Table 77. MEA Respiratory Devices, by Type USD Million (2014-2019)
  • Table 78. MEA Respiratory Devices, by Application USD Million (2014-2019)
  • Table 79. MEA Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 80. Middle East Respiratory Devices, by Type USD Million (2014-2019)
  • Table 81. Middle East Respiratory Devices, by Application USD Million (2014-2019)
  • Table 82. Middle East Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 83. Africa Respiratory Devices, by Type USD Million (2014-2019)
  • Table 84. Africa Respiratory Devices, by Application USD Million (2014-2019)
  • Table 85. Africa Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 86. North America Respiratory Devices, by Country USD Million (2014-2019)
  • Table 87. North America Respiratory Devices, by Type USD Million (2014-2019)
  • Table 88. North America Respiratory Devices, by Application USD Million (2014-2019)
  • Table 89. North America Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 90. United States Respiratory Devices, by Type USD Million (2014-2019)
  • Table 91. United States Respiratory Devices, by Application USD Million (2014-2019)
  • Table 92. United States Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 93. Canada Respiratory Devices, by Type USD Million (2014-2019)
  • Table 94. Canada Respiratory Devices, by Application USD Million (2014-2019)
  • Table 95. Canada Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 96. Mexico Respiratory Devices, by Type USD Million (2014-2019)
  • Table 97. Mexico Respiratory Devices, by Application USD Million (2014-2019)
  • Table 98. Mexico Respiratory Devices, by End-Use USD Million (2014-2019)
  • Table 99. Respiratory Devices Sales: by Type(K Units)
  • Table 100. Respiratory Devices Sales Therapeutic [Ventilator, Mask, PAP Device, Inhaler, Nebulizer] , by Region K Units (2014-2019)
  • Table 101. Respiratory Devices Sales Monitoring [Pulse Oximeter, Capnograph] , by Region K Units (2014-2019)
  • Table 102. Respiratory Devices Sales Diagnostic , by Region K Units (2014-2019)
  • Table 103. Respiratory Devices Sales Consumables , by Region K Units (2014-2019)
  • Table 104. Respiratory Devices Sales: by Application(K Units)
  • Table 105. Respiratory Devices Sales Chronic Obstructive Pulmonary Disease (COPD) , by Region K Units (2014-2019)
  • Table 106. Respiratory Devices Sales Asthma , by Region K Units (2014-2019)
  • Table 107. Respiratory Devices Sales Sleep Apnea , by Region K Units (2014-2019)
  • Table 108. Respiratory Devices Sales Infectious Disease , by Region K Units (2014-2019)
  • Table 109. Respiratory Devices Sales Other , by Region K Units (2014-2019)
  • Table 110. Respiratory Devices Sales: by End-Use(K Units)
  • Table 111. Respiratory Devices Sales Hospital , by Region K Units (2014-2019)
  • Table 112. Respiratory Devices Sales Home Care , by Region K Units (2014-2019)
  • Table 113. Respiratory Devices Sales Ambulatory Care Centers , by Region K Units (2014-2019)
  • Table 114. South America Respiratory Devices Sales, by Country K Units (2014-2019)
  • Table 115. South America Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 116. South America Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 117. South America Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 118. Brazil Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 119. Brazil Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 120. Brazil Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 121. Argentina Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 122. Argentina Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 123. Argentina Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 124. Rest of South America Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 125. Rest of South America Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 126. Rest of South America Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 127. Asia Pacific Respiratory Devices Sales, by Country K Units (2014-2019)
  • Table 128. Asia Pacific Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 129. Asia Pacific Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 130. Asia Pacific Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 131. China Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 132. China Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 133. China Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 134. Japan Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 135. Japan Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 136. Japan Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 137. India Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 138. India Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 139. India Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 140. South Korea Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 141. South Korea Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 142. South Korea Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 143. Taiwan Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 144. Taiwan Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 145. Taiwan Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 146. Australia Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 147. Australia Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 148. Australia Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 149. Rest of Asia-Pacific Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 150. Rest of Asia-Pacific Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 151. Rest of Asia-Pacific Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 152. Europe Respiratory Devices Sales, by Country K Units (2014-2019)
  • Table 153. Europe Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 154. Europe Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 155. Europe Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 156. Germany Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 157. Germany Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 158. Germany Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 159. France Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 160. France Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 161. France Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 162. Italy Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 163. Italy Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 164. Italy Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 165. United Kingdom Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 166. United Kingdom Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 167. United Kingdom Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 168. Netherlands Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 169. Netherlands Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 170. Netherlands Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 171. Rest of Europe Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 172. Rest of Europe Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 173. Rest of Europe Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 174. MEA Respiratory Devices Sales, by Country K Units (2014-2019)
  • Table 175. MEA Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 176. MEA Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 177. MEA Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 178. Middle East Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 179. Middle East Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 180. Middle East Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 181. Africa Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 182. Africa Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 183. Africa Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 184. North America Respiratory Devices Sales, by Country K Units (2014-2019)
  • Table 185. North America Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 186. North America Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 187. North America Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 188. United States Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 189. United States Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 190. United States Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 191. Canada Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 192. Canada Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 193. Canada Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 194. Mexico Respiratory Devices Sales, by Type K Units (2014-2019)
  • Table 195. Mexico Respiratory Devices Sales, by Application K Units (2014-2019)
  • Table 196. Mexico Respiratory Devices Sales, by End-Use K Units (2014-2019)
  • Table 197. Respiratory Devices: by Type(USD/Units)
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Respiratory Devices: by Type(USD Million)
  • Table 212. Respiratory Devices Therapeutic [Ventilator, Mask, PAP Device, Inhaler, Nebulizer] , by Region USD Million (2020-2025)
  • Table 213. Respiratory Devices Monitoring [Pulse Oximeter, Capnograph] , by Region USD Million (2020-2025)
  • Table 214. Respiratory Devices Diagnostic , by Region USD Million (2020-2025)
  • Table 215. Respiratory Devices Consumables , by Region USD Million (2020-2025)
  • Table 216. Respiratory Devices: by Application(USD Million)
  • Table 217. Respiratory Devices Chronic Obstructive Pulmonary Disease (COPD) , by Region USD Million (2020-2025)
  • Table 218. Respiratory Devices Asthma , by Region USD Million (2020-2025)
  • Table 219. Respiratory Devices Sleep Apnea , by Region USD Million (2020-2025)
  • Table 220. Respiratory Devices Infectious Disease , by Region USD Million (2020-2025)
  • Table 221. Respiratory Devices Other , by Region USD Million (2020-2025)
  • Table 222. Respiratory Devices: by End-Use(USD Million)
  • Table 223. Respiratory Devices Hospital , by Region USD Million (2020-2025)
  • Table 224. Respiratory Devices Home Care , by Region USD Million (2020-2025)
  • Table 225. Respiratory Devices Ambulatory Care Centers , by Region USD Million (2020-2025)
  • Table 226. South America Respiratory Devices, by Country USD Million (2020-2025)
  • Table 227. South America Respiratory Devices, by Type USD Million (2020-2025)
  • Table 228. South America Respiratory Devices, by Application USD Million (2020-2025)
  • Table 229. South America Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 230. Brazil Respiratory Devices, by Type USD Million (2020-2025)
  • Table 231. Brazil Respiratory Devices, by Application USD Million (2020-2025)
  • Table 232. Brazil Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 233. Argentina Respiratory Devices, by Type USD Million (2020-2025)
  • Table 234. Argentina Respiratory Devices, by Application USD Million (2020-2025)
  • Table 235. Argentina Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 236. Rest of South America Respiratory Devices, by Type USD Million (2020-2025)
  • Table 237. Rest of South America Respiratory Devices, by Application USD Million (2020-2025)
  • Table 238. Rest of South America Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 239. Asia Pacific Respiratory Devices, by Country USD Million (2020-2025)
  • Table 240. Asia Pacific Respiratory Devices, by Type USD Million (2020-2025)
  • Table 241. Asia Pacific Respiratory Devices, by Application USD Million (2020-2025)
  • Table 242. Asia Pacific Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 243. China Respiratory Devices, by Type USD Million (2020-2025)
  • Table 244. China Respiratory Devices, by Application USD Million (2020-2025)
  • Table 245. China Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 246. Japan Respiratory Devices, by Type USD Million (2020-2025)
  • Table 247. Japan Respiratory Devices, by Application USD Million (2020-2025)
  • Table 248. Japan Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 249. India Respiratory Devices, by Type USD Million (2020-2025)
  • Table 250. India Respiratory Devices, by Application USD Million (2020-2025)
  • Table 251. India Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 252. South Korea Respiratory Devices, by Type USD Million (2020-2025)
  • Table 253. South Korea Respiratory Devices, by Application USD Million (2020-2025)
  • Table 254. South Korea Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 255. Taiwan Respiratory Devices, by Type USD Million (2020-2025)
  • Table 256. Taiwan Respiratory Devices, by Application USD Million (2020-2025)
  • Table 257. Taiwan Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 258. Australia Respiratory Devices, by Type USD Million (2020-2025)
  • Table 259. Australia Respiratory Devices, by Application USD Million (2020-2025)
  • Table 260. Australia Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 261. Rest of Asia-Pacific Respiratory Devices, by Type USD Million (2020-2025)
  • Table 262. Rest of Asia-Pacific Respiratory Devices, by Application USD Million (2020-2025)
  • Table 263. Rest of Asia-Pacific Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 264. Europe Respiratory Devices, by Country USD Million (2020-2025)
  • Table 265. Europe Respiratory Devices, by Type USD Million (2020-2025)
  • Table 266. Europe Respiratory Devices, by Application USD Million (2020-2025)
  • Table 267. Europe Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 268. Germany Respiratory Devices, by Type USD Million (2020-2025)
  • Table 269. Germany Respiratory Devices, by Application USD Million (2020-2025)
  • Table 270. Germany Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 271. France Respiratory Devices, by Type USD Million (2020-2025)
  • Table 272. France Respiratory Devices, by Application USD Million (2020-2025)
  • Table 273. France Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 274. Italy Respiratory Devices, by Type USD Million (2020-2025)
  • Table 275. Italy Respiratory Devices, by Application USD Million (2020-2025)
  • Table 276. Italy Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 277. United Kingdom Respiratory Devices, by Type USD Million (2020-2025)
  • Table 278. United Kingdom Respiratory Devices, by Application USD Million (2020-2025)
  • Table 279. United Kingdom Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 280. Netherlands Respiratory Devices, by Type USD Million (2020-2025)
  • Table 281. Netherlands Respiratory Devices, by Application USD Million (2020-2025)
  • Table 282. Netherlands Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 283. Rest of Europe Respiratory Devices, by Type USD Million (2020-2025)
  • Table 284. Rest of Europe Respiratory Devices, by Application USD Million (2020-2025)
  • Table 285. Rest of Europe Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 286. MEA Respiratory Devices, by Country USD Million (2020-2025)
  • Table 287. MEA Respiratory Devices, by Type USD Million (2020-2025)
  • Table 288. MEA Respiratory Devices, by Application USD Million (2020-2025)
  • Table 289. MEA Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 290. Middle East Respiratory Devices, by Type USD Million (2020-2025)
  • Table 291. Middle East Respiratory Devices, by Application USD Million (2020-2025)
  • Table 292. Middle East Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 293. Africa Respiratory Devices, by Type USD Million (2020-2025)
  • Table 294. Africa Respiratory Devices, by Application USD Million (2020-2025)
  • Table 295. Africa Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 296. North America Respiratory Devices, by Country USD Million (2020-2025)
  • Table 297. North America Respiratory Devices, by Type USD Million (2020-2025)
  • Table 298. North America Respiratory Devices, by Application USD Million (2020-2025)
  • Table 299. North America Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 300. United States Respiratory Devices, by Type USD Million (2020-2025)
  • Table 301. United States Respiratory Devices, by Application USD Million (2020-2025)
  • Table 302. United States Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 303. Canada Respiratory Devices, by Type USD Million (2020-2025)
  • Table 304. Canada Respiratory Devices, by Application USD Million (2020-2025)
  • Table 305. Canada Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 306. Mexico Respiratory Devices, by Type USD Million (2020-2025)
  • Table 307. Mexico Respiratory Devices, by Application USD Million (2020-2025)
  • Table 308. Mexico Respiratory Devices, by End-Use USD Million (2020-2025)
  • Table 309. Respiratory Devices Sales: by Type(K Units)
  • Table 310. Respiratory Devices Sales Therapeutic [Ventilator, Mask, PAP Device, Inhaler, Nebulizer] , by Region K Units (2020-2025)
  • Table 311. Respiratory Devices Sales Monitoring [Pulse Oximeter, Capnograph] , by Region K Units (2020-2025)
  • Table 312. Respiratory Devices Sales Diagnostic , by Region K Units (2020-2025)
  • Table 313. Respiratory Devices Sales Consumables , by Region K Units (2020-2025)
  • Table 314. Respiratory Devices Sales: by Application(K Units)
  • Table 315. Respiratory Devices Sales Chronic Obstructive Pulmonary Disease (COPD) , by Region K Units (2020-2025)
  • Table 316. Respiratory Devices Sales Asthma , by Region K Units (2020-2025)
  • Table 317. Respiratory Devices Sales Sleep Apnea , by Region K Units (2020-2025)
  • Table 318. Respiratory Devices Sales Infectious Disease , by Region K Units (2020-2025)
  • Table 319. Respiratory Devices Sales Other , by Region K Units (2020-2025)
  • Table 320. Respiratory Devices Sales: by End-Use(K Units)
  • Table 321. Respiratory Devices Sales Hospital , by Region K Units (2020-2025)
  • Table 322. Respiratory Devices Sales Home Care , by Region K Units (2020-2025)
  • Table 323. Respiratory Devices Sales Ambulatory Care Centers , by Region K Units (2020-2025)
  • Table 324. South America Respiratory Devices Sales, by Country K Units (2020-2025)
  • Table 325. South America Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 326. South America Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 327. South America Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 328. Brazil Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 329. Brazil Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 330. Brazil Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 331. Argentina Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 332. Argentina Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 333. Argentina Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 334. Rest of South America Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 335. Rest of South America Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 336. Rest of South America Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 337. Asia Pacific Respiratory Devices Sales, by Country K Units (2020-2025)
  • Table 338. Asia Pacific Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 339. Asia Pacific Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 340. Asia Pacific Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 341. China Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 342. China Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 343. China Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 344. Japan Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 345. Japan Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 346. Japan Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 347. India Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 348. India Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 349. India Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 350. South Korea Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 351. South Korea Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 352. South Korea Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 353. Taiwan Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 354. Taiwan Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 355. Taiwan Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 356. Australia Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 357. Australia Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 358. Australia Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 359. Rest of Asia-Pacific Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 360. Rest of Asia-Pacific Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 361. Rest of Asia-Pacific Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 362. Europe Respiratory Devices Sales, by Country K Units (2020-2025)
  • Table 363. Europe Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 364. Europe Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 365. Europe Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 366. Germany Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 367. Germany Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 368. Germany Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 369. France Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 370. France Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 371. France Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 372. Italy Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 373. Italy Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 374. Italy Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 375. United Kingdom Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 376. United Kingdom Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 377. United Kingdom Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 378. Netherlands Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 379. Netherlands Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 380. Netherlands Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 381. Rest of Europe Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 382. Rest of Europe Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 383. Rest of Europe Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 384. MEA Respiratory Devices Sales, by Country K Units (2020-2025)
  • Table 385. MEA Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 386. MEA Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 387. MEA Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 388. Middle East Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 389. Middle East Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 390. Middle East Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 391. Africa Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 392. Africa Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 393. Africa Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 394. North America Respiratory Devices Sales, by Country K Units (2020-2025)
  • Table 395. North America Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 396. North America Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 397. North America Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 398. United States Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 399. United States Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 400. United States Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 401. Canada Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 402. Canada Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 403. Canada Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 404. Mexico Respiratory Devices Sales, by Type K Units (2020-2025)
  • Table 405. Mexico Respiratory Devices Sales, by Application K Units (2020-2025)
  • Table 406. Mexico Respiratory Devices Sales, by End-Use K Units (2020-2025)
  • Table 407. Respiratory Devices: by Type(USD/Units)
  • Table 408. Research Programs/Design for This Report
  • Table 409. Key Data Information from Secondary Sources
  • Table 410. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Respiratory Devices: by Type USD Million (2014-2019)
  • Figure 5. Global Respiratory Devices: by Application USD Million (2014-2019)
  • Figure 6. Global Respiratory Devices: by End-Use USD Million (2014-2019)
  • Figure 7. South America Respiratory Devices Share (%), by Country
  • Figure 8. Asia Pacific Respiratory Devices Share (%), by Country
  • Figure 9. Europe Respiratory Devices Share (%), by Country
  • Figure 10. MEA Respiratory Devices Share (%), by Country
  • Figure 11. North America Respiratory Devices Share (%), by Country
  • Figure 12. Global Respiratory Devices: by Type K Units (2014-2019)
  • Figure 13. Global Respiratory Devices: by Application K Units (2014-2019)
  • Figure 14. Global Respiratory Devices: by End-Use K Units (2014-2019)
  • Figure 15. South America Respiratory Devices Share (%), by Country
  • Figure 16. Asia Pacific Respiratory Devices Share (%), by Country
  • Figure 17. Europe Respiratory Devices Share (%), by Country
  • Figure 18. MEA Respiratory Devices Share (%), by Country
  • Figure 19. North America Respiratory Devices Share (%), by Country
  • Figure 20. Global Respiratory Devices: by Type USD/Units (2014-2019)
  • Figure 21. Global Respiratory Devices share by Players 2019 (%)
  • Figure 22. Global Respiratory Devices share by Players (Top 3) 2019(%)
  • Figure 23. Global Respiratory Devices share by Players (Top 5) 2019(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. First Sensor AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. First Sensor AG (Germany) Revenue: by Geography 2019
  • Figure 27. Philips Healthcare, (Netherlands) Revenue, Net Income and Gross profit
  • Figure 28. Philips Healthcare, (Netherlands) Revenue: by Geography 2019
  • Figure 29. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. Medtronic plc (Ireland) Revenue: by Geography 2019
  • Figure 31. ResMed Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. ResMed Inc. (United States) Revenue: by Geography 2019
  • Figure 33. Masimo Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 34. Masimo Corporation (United States) Revenue: by Geography 2019
  • Figure 35. Fisher & Paykel Healthcare Co. Ltd. (NewZealand) Revenue, Net Income and Gross profit
  • Figure 36. Fisher & Paykel Healthcare Co. Ltd. (NewZealand) Revenue: by Geography 2019
  • Figure 37. Getinge AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 38. Getinge AB (Sweden) Revenue: by Geography 2019
  • Figure 39. Air Liquide (France) Revenue, Net Income and Gross profit
  • Figure 40. Air Liquide (France) Revenue: by Geography 2019
  • Figure 41. Drägerwerk AG & CO.KGAA (Germany) Revenue, Net Income and Gross profit
  • Figure 42. Drägerwerk AG & CO.KGAA (Germany) Revenue: by Geography 2019
  • Figure 43. Hamilton Medical AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 44. Hamilton Medical AG (Switzerland) Revenue: by Geography 2019
  • Figure 45. Invacare Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 46. Invacare Corporation (United States) Revenue: by Geography 2019
  • Figure 47. Vyaire Medical (United States) Revenue, Net Income and Gross profit
  • Figure 48. Vyaire Medical (United States) Revenue: by Geography 2019
  • Figure 49. Chart Industries, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 50. Chart Industries, Inc. (United States) Revenue: by Geography 2019
  • Figure 51. Global Respiratory Devices: by Type USD Million (2020-2025)
  • Figure 52. Global Respiratory Devices: by Application USD Million (2020-2025)
  • Figure 53. Global Respiratory Devices: by End-Use USD Million (2020-2025)
  • Figure 54. South America Respiratory Devices Share (%), by Country
  • Figure 55. Asia Pacific Respiratory Devices Share (%), by Country
  • Figure 56. Europe Respiratory Devices Share (%), by Country
  • Figure 57. MEA Respiratory Devices Share (%), by Country
  • Figure 58. North America Respiratory Devices Share (%), by Country
  • Figure 59. Global Respiratory Devices: by Type K Units (2020-2025)
  • Figure 60. Global Respiratory Devices: by Application K Units (2020-2025)
  • Figure 61. Global Respiratory Devices: by End-Use K Units (2020-2025)
  • Figure 62. South America Respiratory Devices Share (%), by Country
  • Figure 63. Asia Pacific Respiratory Devices Share (%), by Country
  • Figure 64. Europe Respiratory Devices Share (%), by Country
  • Figure 65. MEA Respiratory Devices Share (%), by Country
  • Figure 66. North America Respiratory Devices Share (%), by Country
  • Figure 67. Global Respiratory Devices: by Type USD/Units (2020-2025)
List of companies from research coverage that are profiled in the study
  • First Sensor AG (Germany)
  • Philips Healthcare, (Netherlands)
  • Medtronic plc (Ireland)
  • ResMed Inc. (United States)
  • Masimo Corporation (United States)
  • Fisher & Paykel Healthcare Co. Ltd. (NewZealand)
  • Getinge AB (Sweden)
  • Air Liquide (France)
  • Drägerwerk AG & CO.KGAA (Germany)
  • Hamilton Medical AG (Switzerland)
  • Invacare Corporation (United States)
  • Vyaire Medical (United States)
  • Chart Industries, Inc. (United States)
Select User Access Type

Key Highlights of Report


Apr 2020 219 Pages 70 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Respiratory Devices Quantitative research analysis
Global Respiratory Devices Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Respiratory Devices Report?

Have a Query? Click Here

Other Related Reports

Occlusion Devices Comprehensive Study by Type (Occlusion Balloon, Stent Retriever, Suction Device, Coil Embolization, Liquid Embolics), Application (Cardiology, Neurology, Peripheral Vascular, Urolog...
$ 3650
Human Identification Comprehensive Study by Type (Lab Instruments, Lab Reagents and Chemicals, Kits and Assays, Software and Digital Storage, Others), Application (Offender DNA Data Basing, Forensic ...
$ 3750
Hearing Care Devices Comprehensive Study by Type (Hearing Aids, Hearing Implants), Application (Hospitals & Clinics, Home Settings, Ambulatory Surgical Centers (ASCs)), Type of Hearing Loss (Sensorin...
$ 3500
Surgical Microscopes Comprehensive Study by Type (On Caster, Wall Mounted, Table Top, Ceiling Mounted), Application (Neuro and Spine Surgery, Plastic and Reconstructive Surgery, Ear, Nose, and Throat...
$ 3650
Weight Loss Stomach Pump Comprehensive Study by Application (Clinics, Hospitals, Nursing Homes, Others), Disease Type (Anorexia, Bulimia, Diabetes, Others) Players and Region - Global Market Outlook ...
$ 3500
In Vitro Fertilization Device Comprehensive Study by Type (Dry Incubators, ICSI or IMSI, Centrifuge, Ovum Aspiration Pumps, Laser Hatching System, Cryo Cans, Embryoscope, Others), Application (Surgic...
$ 3800